CDC: Obesity, diabetes on the rise among Americans
WASHINGTON A new survey released this week by the Centers for Disease Control and Prevention’s National Center for Health Statistics found that obesity and diabetes rates are at peak levels since the data collection for such conditions began more than 10 years ago.
The 2009 National Health Interview Survey, which was based on interviews with 88,129 people, found that the prevalence of obesity in U.S. adults (ages 20 years and older) was 28%. The highest obesity rate was found among adults ages 40 to 59 years. The disparity between men and women was not statistically profound, the survey noted.
Similarly, diabetes rates among U.S. adults also rose to 9% in 2009, from 5.1% in 1997. Diabetes also was more prevalent among older adults than younger adults, the survey results showed. More Hispanics and African-Americans were diagnosed with diabetes, compared with whites.
Click here to read the full report.
FDA approves Jevtana
SILVER SPRING, Md. The Food and Drug Administration has approved a new treatment for advanced prostate cancer, the agency said Thursday.
The FDA announced the approval of Sanofi-Aventis’ Jevtana (cabazitaxel), a chemotherapy drug used with the steroid prednisone. The agency said the drug was the first treatment for advanced, hormone-refractory prostate cancer that has worsened during or after treatment with docetaxel, also a chemotherapy drug used in advanced prostate cancer. Hormone refractory prostate cancer happens when prostate tumors continue to grow despite treatments meant to reduce the body’s production of the male hormone testosterone, which helps prostate tumors grow.
“Patients have few therapeutic options in this disease setting,” FDA Center for Drug Evaluation and Research Office of Oncology Products director Richard Pazdur said. “FDA was able to review and approve the application for Jevtana in 11 weeks, expediting the availability of this drug to men with prostate cancer.”
Report: Oregon State Board of Pharmacy declares marijuana as drug with medical use
SALEM, Ore. The makers of the 1930s documentary “Reefer Madness” would be furious at the news, but it likely will come as a relief to people with certain diseases and marijuana law-reform advocates.
The Oregon State Board of Pharmacy voted Wednesday to have marijuana classified as a drug with medical use, according to reports from a local TV station. The decision makes the state to reclassify it as such.
Under the decision, marijuana will be known as a Schedule II controlled substance, meaning that it has high potential for abuse but still has medical benefits. Previously — and still in all other states — marijuana was a Schedule I drug, meaning it had no medical benefits.